(Q45295291)

English

Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization

scientific article published on 3 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 December 2017

Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization (English)

1 reference

Europe PubMed Central

11 December 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

11 December 2017

3

1 reference

Europe PubMed Central

11 December 2017

author name string

Eun Sun Jang

1

1 reference

Europe PubMed Central

11 December 2017

Eun Ju Cho

4

1 reference

Europe PubMed Central

11 December 2017

Su Jong Yu

5

1 reference

Europe PubMed Central

11 December 2017

Jeong-Hoon Lee

6

1 reference

Europe PubMed Central

11 December 2017

Yoon Jun Kim

7

1 reference

Europe PubMed Central

11 December 2017

Hyo-Suk Lee

8

1 reference

Europe PubMed Central

11 December 2017

Chung Yong Kim

9

1 reference

Europe PubMed Central

11 December 2017

publication date

3 January 2013

1 reference

Europe PubMed Central

11 December 2017

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

11 December 2017

139

1 reference

Europe PubMed Central

11 December 2017

4

1 reference

Europe PubMed Central

11 December 2017

635-643

1 reference

Europe PubMed Central

11 December 2017

https://scigraph.springernature.com/pub.10.1007/s00432-012-1364-2

0 references

Resectability of large focal liver lesions

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Performance status assessment in cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Infiltrating hepatocellular carcinoma: seeing the tree through the forest

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Current strategy for staging and treatment: the BCLC update and future prospects.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Chemoembolization in patients at high risk: results and complications.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: a multivariate analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Transcatheter arterial chemo-lipiodol infusion for unresectable hepatocellular carcinoma in 96 high-risk patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Gross Pathologic Types of Hepatocellular Carcinoma in Italy

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1364-2

21 January 2018

Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nourishment of hepatocellular carcinoma cells through the portal blood flow with and without transcatheter arterial embolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma supplied by portal flow after repeated transcatheter arterial chemoembolization

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoembolization of hepatocellular carcinoma: results of a metaanalysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A clinical and pathological study of diffuse type hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/23283527

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-012-1364-2

1 reference

Europe PubMed Central

11 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45295291&oldid=2074079128"